Francesco Greco1, Riccardo Autorino2, Vincenzo Altieri3, Steven Campbell4, Vincenzo Ficarra5, Inderbir Gill6, Alexander Kutikov7, Alex Mottrie8, Vincenzo Mirone9, Hendrik van Poppel10. 1. Department of Urology, Humanitas Gavazzeni, Bergamo, Italy. Electronic address: francesco_greco@ymail.com. 2. Division of Urology, Virginia Commonwealth University, Richmond, VA, USA. 3. Department of Urology, Humanitas Gavazzeni, Bergamo, Italy. 4. Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA. 5. Department of Human Pathology of Adult and Evolutive Age, University of Messina, Messina, Italy. 6. Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California Institute of Urology, Los Angeles, CA, USA. 7. Division of Urologic Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, USA. 8. Department of Urology, Onze-Lieve-Vrouw Hospital, Aalst, Belgium. 9. Department of Urology, Federico II University, Naples, Italy. 10. Katholieke Universiteit Leuven, Leuven, Belgium.
Abstract
CONTEXT: The optimal ischemia technique at partial nephrectomy (PN) for renal masses is yet to be determined. OBJECTIVE: To summarize and analyze the current evidence about surgical, oncological, and functional outcomes after different ischemia techniques (cold, warm, and zero ischemia) at PN. EVIDENCE ACQUISITION: A computerized systematic literature search was performed by using PubMed (MEDLINE) and Science Direct. Identification and selection of the studies were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) criteria. Outcomes of interest were estimated blood loss (EBL), overall complications, positive surgical margins, local tumor recurrence, and renal function preservation. Meta-analysis and forest-plot diagrams were performed. Overall pooled estimates, together with 95% confidence intervals (CIs), of the incidence of all parameters were obtained using a random effect model (RE-Model) on the log transformed means (MLN), proportion, or standardized mean change, as deemed appropriate. EVIDENCE SYNTHESIS: One hundred and fifty-six studies were included. No clinically meaningful differences were found in terms of EBL after cold (mean: 215.5; 95% CI: 154.2-276.8m), warm (mean: 201.8; 95% CI: 175.0-228.7ml), or zero (mean: 261.2; 95% CI: 171.0-351.3ml) ischemia technique. Overall, postoperative complications were recorded in 14.1% (95% CI: 6.7-27.4), 11.1% (95% CI: 10.0-12.3), and 9.7% (95% CI: 7.7-12.2) of patients after cold, warm, and zero ischemia (p<0.01), respectively. Positive surgical margins were recorded in 4.8% (95% CI: 1.9-10.9), 4.0% (95% CI: 3.4-4.8), and 5.6% (95% CI: 3.1-9.8) of patients after cold, warm, and zero ischemia (p<0.01), respectively. Local recurrence was recorded in 3.2% (95% CI: 1.9-5.2) and 3.1% (95% CI: 0.7-11.5) of patients after warm and zero ischemia (p<0.01), respectively. The log2 of estimated glomerular filtration ratio mean changes were-1.37 (95% CI:-3.42 to 0.68),-1.00 (-2.04 to 0.03), and-0.71 (-1.15 to-0.27) ml/min after cold, warm, and zero ischemia, respectively. Low level of evidence, retrospective nature of most of included studies, a high risk of selection bias, and heterogeneity within included studies limited the overall quality of the analysis. CONCLUSIONS: The effect of ischemia technique at PN is still debatable and subject to confounding by several factors, namely, patients' selection criteria, surgical technique used, and percentage of functional parenchyma spared during surgery. These confounders bias available evidence and were addressed by only a small part of available studies. Unfortunately, the overall quality of literature evidences and the high risk of selection bias limit the possibility of any causal interpretation about the relationship between the ischemia technique used and surgical, oncological, or functional outcomes. Thus, none of the available ischemia technique could be recommended over the other. PATIENT SUMMARY: The present analysis shows that none of the available ischemia techniques, namely, cold, warm, or zero ischemia, is universally superior to the others, and other factors play a role in the surgical outcome.
CONTEXT: The optimal ischemia technique at partial nephrectomy (PN) for renal masses is yet to be determined. OBJECTIVE: To summarize and analyze the current evidence about surgical, oncological, and functional outcomes after different ischemia techniques (cold, warm, and zero ischemia) at PN. EVIDENCE ACQUISITION: A computerized systematic literature search was performed by using PubMed (MEDLINE) and Science Direct. Identification and selection of the studies were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) criteria. Outcomes of interest were estimated blood loss (EBL), overall complications, positive surgical margins, local tumor recurrence, and renal function preservation. Meta-analysis and forest-plot diagrams were performed. Overall pooled estimates, together with 95% confidence intervals (CIs), of the incidence of all parameters were obtained using a random effect model (RE-Model) on the log transformed means (MLN), proportion, or standardized mean change, as deemed appropriate. EVIDENCE SYNTHESIS: One hundred and fifty-six studies were included. No clinically meaningful differences were found in terms of EBL after cold (mean: 215.5; 95% CI: 154.2-276.8m), warm (mean: 201.8; 95% CI: 175.0-228.7ml), or zero (mean: 261.2; 95% CI: 171.0-351.3ml) ischemia technique. Overall, postoperative complications were recorded in 14.1% (95% CI: 6.7-27.4), 11.1% (95% CI: 10.0-12.3), and 9.7% (95% CI: 7.7-12.2) of patients after cold, warm, and zero ischemia (p<0.01), respectively. Positive surgical margins were recorded in 4.8% (95% CI: 1.9-10.9), 4.0% (95% CI: 3.4-4.8), and 5.6% (95% CI: 3.1-9.8) of patients after cold, warm, and zero ischemia (p<0.01), respectively. Local recurrence was recorded in 3.2% (95% CI: 1.9-5.2) and 3.1% (95% CI: 0.7-11.5) of patients after warm and zero ischemia (p<0.01), respectively. The log2 of estimated glomerular filtration ratio mean changes were-1.37 (95% CI:-3.42 to 0.68),-1.00 (-2.04 to 0.03), and-0.71 (-1.15 to-0.27) ml/min after cold, warm, and zero ischemia, respectively. Low level of evidence, retrospective nature of most of included studies, a high risk of selection bias, and heterogeneity within included studies limited the overall quality of the analysis. CONCLUSIONS: The effect of ischemia technique at PN is still debatable and subject to confounding by several factors, namely, patients' selection criteria, surgical technique used, and percentage of functional parenchyma spared during surgery. These confounders bias available evidence and were addressed by only a small part of available studies. Unfortunately, the overall quality of literature evidences and the high risk of selection bias limit the possibility of any causal interpretation about the relationship between the ischemia technique used and surgical, oncological, or functional outcomes. Thus, none of the available ischemia technique could be recommended over the other. PATIENT SUMMARY: The present analysis shows that none of the available ischemia techniques, namely, cold, warm, or zero ischemia, is universally superior to the others, and other factors play a role in the surgical outcome.
Authors: Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Marc Colombel; Laurence Klotz; Eila Skinner; Thomas Keane; Sandrine Marreaud; Sandra Collette; Richard Sylvester Journal: Eur Urol Date: 2010-12-22 Impact factor: 20.096
Authors: C A Jilg; Hartmut P H Neumann; S Gläsker; O Schäfer; C Leiber; P U Ardelt; M Schwardt; W Schultze-Seemann Journal: Fam Cancer Date: 2012-09 Impact factor: 2.375
Authors: Maria C Mir; Cesar Ercole; Toshio Takagi; Zhiling Zhang; Lily Velet; Erick M Remer; Sevag Demirjian; Steven C Campbell Journal: J Urol Date: 2015-01-29 Impact factor: 7.450
Authors: Inderbir S Gill; Mihir M Desai; Jihad H Kaouk; Anoop M Meraney; David P Murphy; Gyung Tak Sung; Andrew C Novick Journal: J Urol Date: 2002-02 Impact factor: 7.450
Authors: Tyler R McClintock; Marc A Bjurlin; James S Wysock; Michael S Borofsky; Tracy P Marien; Chinonyerem Okoro; Michael D Stifelman Journal: Urology Date: 2014-06-06 Impact factor: 2.649
Authors: Anup P Ramani; Mihir M Desai; Andrew P Steinberg; Christopher S Ng; Sidney C Abreu; Jihad H Kaouk; Antonio Finelli; Andrew C Novick; Inderbir S Gill Journal: J Urol Date: 2005-01 Impact factor: 7.450
Authors: Kevin C Zorn; Edward M Gong; Marcelo A Orvieto; Ofer N Gofrit; Albert A Mikhail; Lambda P Msezane; Arieh L Shalhav Journal: Urology Date: 2007-06 Impact factor: 2.649
Authors: Fernando J Kim; Koon H Rha; Fernando Hernandez; Thomas W Jarrett; Peter A Pinto; Louis R Kavoussi Journal: J Urol Date: 2003-08 Impact factor: 7.450
Authors: Clément Michiels; Zine-Eddine Khene; Thomas Prudhomme; Astrid Boulenger de Hauteclocque; François H Cornelis; Mélanie Percot; Hélène Simeon; Laure Dupitout; Henri Bensadoun; Grégoire Capon; Eric Alezra; Vincent Estrade; Franck Bladou; Grégoire Robert; Jean-Marie Ferriere; Nicolas Grenier; Nicolas Doumerc; Karim Bensalah; Jean-Christophe Bernhard Journal: World J Urol Date: 2021-04-02 Impact factor: 4.226